CClinicalTrials.gg
RecruitingNCT06449573Updated Aug 27, 2024

Evaluation of Cardiopulmonary Parameters in Individuals With Asthma

An observational study in Asthma, sponsored by Hacettepe University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-27.

Sponsored by Hacettepe University · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2025, 1 year 7 months ago, but the record still lists the study as recruiting.
  • Started Mar 2024; still recruiting 2 years 7 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
15
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of the study compare the cardiopulmonary parameters of individuals with asthma with healthy subjects.

Read the detailed description

It is thought that aerobic capacity of asthmatic individuals decreases due to chronic respiratory disease, especially oxygen consumption. Detailed investigation will be provided with this research.

02

Conditions studied

  • Asthma

Browse trials for

03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 506 are open to participants now.

This study's planned enrollment of 15 is below the median of 150 across 970 observational studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study will include asthma patients followed up by Hacettepe University Faculty of Medicine, Department of Chest Diseases, Immunology and Allergy Branch and healthy individuals.

Inclusion criteria

  • No respiratory, cardiovascular and metabolic diseases
  • Regular non-smoker

Exclusion criteria

Exclusion Criteria:

  • Non-consenting
  • Pregnant women
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
15 participants (estimated)
Patient registry
No

Groups and cohorts

  • Asthma

    Inclusion Criteria: * Patients receiving step 5 asthma treatment * 18-65 years * Asthma under control (asthma control test ≥20) * No more than 2 exacerbations in the last 1 year Exclusion Criteria: * Non-consenting * Patients with asthma exacerbation requiring systemic steroid use for at least 3 days in the last 1 month * Being an active smoker

    Other: Exercise capacity

  • Healthy Individuals

    Inclusion Criteria: * No respiratory, cardiovascular and metabolic diseases * Regular non-smoker Exclusion Criteria: * Non-consenting * Pregnant women

    Other: Exercise capacity

Interventions

  • OtherExercise capacity

    cardiopulmonary exercise test used assessment of exercise capacity

06

What researchers measure

Primary outcomes

  1. Exercise capacity

    Exercise capacity will be assessed by Cardiopulmonary Exercise Test. The test will be performed on a bicycle ergometer. The test will be terminated when the target heart rate is reached or when the patient indicates that they are unable to continue the test. maximal oxygen consumption and the workload achieved will be recorded.

    Time frame: 20 minutes

Secondary outcomes

  1. Respiratory muscle strength

    Inspiratory and expiratory muscle strength will be measured with a mouth pressure measuring device. Measurements will be made in a sitting position with the hip and knee at 90 degrees and the trunk upright.

    Time frame: 8 minutes

  2. Peripheral muscle strength

    It will be evaluated with a portable manual muscle strength measuring device. Muscle strength of knee extensors will be measured. The measurement will be performed with the patient sitting with his/her back unsupported and his/her hands crossed on his/her chest.

    Time frame: 5 minutes

  3. Grip strength

    It will be evaluated with a portable hand dynamometer. Measurements will be made in a sitting position with the hip and knee at 90 degrees and the trunk upright. The measurement will be performed with the arm adjacent to the side of the trunk and the forearm parallel to the ground.

    Time frame: 3 minutes

  4. Kinesiophobia

    Tampa Kinesiophobia Scale will be used. A total of 17 questions will be answered in 4-point Likert form. In total, the patient scores between 17-68. A high score indicates high kinesiophobia.

    Time frame: 3 minutes

  5. Quality of Life (symptoms, mood, activity limitation, environmental exposure)

    Asthma Quality of Life Scale will be used for the evaluation. This scale consists of 4 sub-headings including symptoms, mood, activity limitation, environmental exposure and 32 questions. Each item is scored between 1-7. The total score of the scale is calculated by averaging the scores given to the items. The higher the score, the better the quality of life.

    Time frame: 10 minutes

07

Study locations

1 of 1 sites recruiting
  • Hacettepe University
    Ankara, Turkey
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06449573
Lead sponsor
Hacettepe University
Responsible party
Aydan Aslı Aksel Uylar (Physiotherapist, Hacettepe University) — Principal investigator
First posted
Jun 10, 2024
Start date
Mar 1, 2024
Primary completion
Mar 2025 (estimated)
Completion
Mar 2025 (estimated)
Last update
Aug 27, 2024

Study contacts

Aydan Aslı Aksel Uylar
Contact
aydanaaksel@gmail.com
+90312 ext. 3051576
Naciye Vardar Yagli
study director · Hacettepe University
Melda Saglam
study chair · Hacettepe University
Ebru Damadoglu
study chair · Hacettepe University
Merve Firat
study chair · Kirsehir Ahi Evran Universitesi
Aydan Aslı Aksel Uylar
principal investigator · Hacettepe University
Melek Cihanbeylerden
study chair · Hacettepe University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion